The paper defines the Morphogenic Tension Principle, explaining its role in systemic health and cancer risks.
This paper introduces and formally defines the Morphogenic Tension Principle (MTP), an original theoretical framework proposed herein as a universal law governing the dynamic equilibrium of multicellular living systems. MTP postulates that every living biological system exists in a continuous, perpetual opposition between two fundamental forces: the morphogenic force (F_M) characterized by differentiated, structurally organized, growth-constrained cellular activity and the amorphogenic force (F_A) characterized by undifferentiated, structurally unconstrained, proliferative cellular activity. The biological integrity of any living system is defined herein as a function of the sustained dominance of F_M over F_A. We formalize this principle through the Morphogenic Dominance Index Phi(t), a scalar ratio of measurable biological parameters, and derive from it quantitative conditions for systemic health, oncogenic transition, and organismal death. Convergent evidence from developmental biology, oncology, non-equilibrium thermodynamics, and complexity theory is marshaled in support of MTP's validity. The principle generates testable predictions regarding cancer-risk biomarker panels and differentiation-based therapeutic strategies. A program for empirical validation is outlined .
No takes yet. Share an insight, caveat, or question.
Momen Ghazouani (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: